BRIEF published on 04/23/2026 at 15:15, 1 month 29 days ago Newron Pharmaceuticals annonce les résultats de son assemblée générale annuelle 2026 Newron Pharmaceuticals Evenamide Membres Du Conseil D'administration Assemblée Générale Annuelle 2026 Xadago®
BRIEF published on 04/23/2026 at 15:15, 1 month 29 days ago Newron Pharmaceuticals Announces AGM 2026 Results Board Members Newron Pharmaceuticals Evenamide AGM 2026 Xadago®
PRESS RELEASE published on 04/23/2026 at 15:10, 1 month 29 days ago Newron announces AGM 2026 results Newron Pharmaceuticals S.p.A. announces successful AGM 2026 results including new Board members. Focus on developing therapies for nervous system diseases Board Members Newron Pharmaceuticals Thérapies AGM 2026 Nervous System Diseases
BRIEF published on 03/24/2026 at 07:05, 2 months 29 days ago Newron annonce ses résultats pour 2025 et ses perspectives pour 2026. Résultats Financiers Traitement De La Schizophrénie Perspectives Pour 2026 Brevet Accordé Essais Sur L'Evenamide
BRIEF published on 03/24/2026 at 07:05, 2 months 29 days ago Newron Announces 2025 Results and 2026 Outlook Financial Results Schizophrenia Treatment Patent Grant 2026 Outlook Evenamide Trials
PRESS RELEASE published on 03/24/2026 at 07:00, 2 months 29 days ago Newron presents 2025 financial results and provides 2026 outlook Newron Pharmaceuticals S.p.A. presents 2025 financial results and 2026 outlook, including progress on evenamide clinical trials and IP expansion Financial Results Clinical Trials Newron Pharmaceuticals 2026 Outlook IP Expansion
BRIEF published on 03/20/2026 at 07:05, 3 months 2 days ago Newron Pharmaceuticals to Present at SIRS 2026 Newron Pharmaceuticals Evenamide Treatment-resistant Schizophrenia Glutamate Modulation Schizophrenia Research
BRIEF published on 03/20/2026 at 07:05, 3 months 2 days ago Newron Pharmaceuticals présentera ses travaux au SIRS 2026 Newron Pharmaceuticals Evenamide Schizophrénie Résistante Au Traitement Modulation Du Glutamate Recherche Sur La Schizophrénie
PRESS RELEASE published on 03/20/2026 at 07:00, 3 months 2 days ago Newron to present at the 2026 Annual Congress of the Schizophrenia International Research Society (SIRS) Newron Pharmaceuticals S.p.A. to present at SIRS 2026 Congress on glutamatergic modulation in treatment-resistant schizophrenia Schizophrenia Newron Pharmaceuticals Congress Glutamatergic Modulation SIRS
BRIEF published on 03/19/2026 at 07:05, 3 months 3 days ago Newron Pharmaceuticals Extends Loan Repayment with EIB European Investment Bank Newron Pharmaceuticals Evenamide Finance Contract ENIGMA-TRS Phase III
Published on 06/22/2026 at 23:25, 2 hours 23 minutes ago Infield Minerals Announces Intention to Issue Shares for Kings Canyon Gold Property Option Payment
Published on 06/22/2026 at 23:05, 2 hours 43 minutes ago Gamma Resources Settles Remaining Balance of Outstanding Debt
Published on 06/22/2026 at 21:05, 4 hours 43 minutes ago RUM Announces Voting Results From Annual General Meeting of Shareholders
Published on 06/22/2026 at 19:45, 6 hours 3 minutes ago Trans Canada Gold Appoints Paradigm Drilling Ltd. for Drilling at the Harrison Lake District Scale Gold Project, Drilling to Commence Shortly
Published on 06/22/2026 at 15:58, 9 hours 50 minutes ago Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/23/2026 at 01:35, 12 minutes ago DoH and Sanofi Partner to Advance Vaccine Innovation
Published on 06/22/2026 at 21:07, 4 hours 40 minutes ago EQS-Adhoc: RWE Aktiengesellschaft: RWE sets placement price for shares from capital measure and raises gross proceeds of 4 billion EUR
Published on 06/22/2026 at 20:50, 4 hours 57 minutes ago Ethlabs, Founded by Former Ethereum Foundation Contributors and Funded by Bitmine, Sharplink and Joe Lubin, Launches to Accelerate Ethereum's Institutional Supercycle
Published on 06/22/2026 at 20:32, 5 hours 15 minutes ago EQS-Adhoc: Deutsche Konsum Real Estate AG: Daniel Löhken appointed Chief Executive Officer of the Company and Dr Kai Gregor Klinger appointed new Chairman of the Supervisory Board
Published on 06/22/2026 at 19:27, 6 hours 20 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 06/22/2026 at 18:00, 7 hours 48 minutes ago GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION
